Global Tissue Extraction System Market Overview
Tissue extraction also known as biopsy is the process of removing tissue sample from the body. The tissues are often extracted to diagnose a disease such as cancer or to assist in understanding a better therapy option. Cancer is uncontrolled growth of cell and can spread to different organs and other parts of the body. Since the imaging technologies can only detect the abnormal mass or lesions but cannot distinguish between cancerous and non-cancerous cells, tissue extraction procedure plays a significant role in the diagnosis of various types of cancers. Mainly to remove a small amount of tissue in the affected part of the body the extraction systems use sharp tools. There are various types of biopsy systems used, such as vacuum assisted biopsy and needle biopsy.
Market Size & Forecast
Tissue Extraction System Market is anticipated to record a significant CAGR over the forecast period. Many multi-national companies are concentrating towards new product advances in tissue extraction systems. Moreover, the numerous ongoing R&D activities and advancements in tissue extraction technologies are anticipated to propel the market growth over the forecast period i.e. 2018-2027. At present the global tissue extraction system market is observing vibrant growth owing to increasing demand for diagnostic drives in cancer research and diagnosis. Furthermore, increasing prevalence of cancer across the globe is additionally predicted to expand the global tissue extraction systems market.
On the basis of regional platform, global tissue extraction system market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America is estimated to rule the global tissue extraction system market in terms of revenue generation and volume owing to high health awareness among patients and practitioners, presence of sophisticated healthcare infrastructure, and favorable government initiatives behaving as few of the factors attributing to the rise of market in North American region. North-America will be followed by Europe in extraction systems market.
The Asia Pacific region is predicted show a high growth rate resulting in being the most lucrative region in the global tissue extraction systems market due to factors like unmet patient needs, rising awareness among people and rapidly developing healthcare infrastructure in the developing countries such as India and China.
CLICK TO DOWNLOAD SAMPLE REPORT
Market Segmentation
Our-in depth analysis of the global tissue extraction system market includes the following segments:
By Application
- Bone Marrow Biopsy
- Needle Biopsy
- Core Needle Biopsy
- Fine Needle Aspiration
- Vacuum – assisted biopsy
- Image Guided Biopsy
- Endoscopic Extraction
- Others
By End-User
- Hospitals
- Cancer Research Centers
- Diagnostic Centers
By Region
Global Tissue Extraction System Market is further classified on the basis of region as follows:
- North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Growth Drivers & Challenges
The tissue extraction system market is forecasted to exhibit a striking growth rate in the forecast years globally owing to the necessity for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of cancer could be among primary factors augmenting the demand in the market. According to WHO, cancer is the leading cause of mortality and morbidity globally impacting about 14 million people annually. The technological advancement in imaging technology such as MRI, CT-Scan, PET scan and others are expected to propel the growth of the global tissue extraction system market during the forecast period. The induction of minimally invasive procedures such as liquid biopsy is an additional factor attributing to the growth of the global tissue extraction system market.
Furthermore, rise in awareness among people about cancer diagnosis with increasing population with unhealthy lifestyles and rise in geriatric population are few factors that are expected to propel the growth of the tissue extraction systems market. However, the cost constraints linked with advanced biopsy technologies along with insecurity entangled in the regulations of medical devices are the factors that can behave as limitations in the growth of the global tissue extraction system market during the forecast period.
Top Featured Companies Dominating The Market
- Hologic, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- DTR Medical Ltd.
- Devicor Medical Products, Inc.
- Cardinal Health
- Argon Medical Devices, Inc.
- Becton, Dickinson and Company
- Olympus Medical Systems Group
- Gerhardt Analytical Systems
- SLEE Medical
- VELP Scientifica
